AAPG

Ascentage Pharma
AAPG

12 hedge funds and large institutions have $1.25M invested in Ascentage Pharma in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

66% less capital invested

Capital invested by funds: $3.69M → $1.25M (-$2.43M)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$548K
2
+$2.78K
3
+$2.72K
4
Bank of America
Bank of America
North Carolina
+$687
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$196

Top Sellers

1
-$462K
2
-$412K
3
-$405K
4
AA
ABC Arbitrage
France
-$204K
5
XC
XY Capital
Hong Kong
-$147K
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$439K
XC
2
XY Capital
Hong Kong
$358K
Citadel Advisors
3
Citadel Advisors
Florida
$255K
UBS Group
4
UBS Group
Switzerland
$111K
Mirae Asset Global Investments
5
Mirae Asset Global Investments
South Korea
$66.8K
TRCT
6
Tower Research Capital (TRC)
New York
$6.04K
Osaic Holdings
7
Osaic Holdings
Arizona
$5.77K
Bank of America
8
Bank of America
North Carolina
$5.27K
Morgan Stanley
9
Morgan Stanley
New York
$4.01K
BIA
10
Bell Investment Advisors
California
$1.76K
EWA
11
EverSource Wealth Advisors
Alabama
$630
NIM
12
NEOS Investment Management
Connecticut
–
TE
13
Tema ETFs
New York
–
AA
14
ABC Arbitrage
France
–
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
–